% | $
Quotes you view appear here for quick access.

công ty Questcor Pharmaceuticals Message Board

  • staff9128 staff9128 Aug 22, 2011 6:34 PM Flag

    Forbes Article

    My favorite parts:

    "Moving forward, Questcor will continue to benefit from its strong financial profile, with cash and short-term investments up $36 million to $129 million against no long-term debt.


    Although we didn’t see any movement in the current-year estimate off the good quarter, pegged at 88 cents, the next-year estimate added 22 cents to $1.35, a bullish 52% growth projection.


    But in spite of the gains, the valuation picture looks great, with a PEG ratio of .60, well below the traditional benchmark of 1 for value.

    On the chart, shares recently hit a new multi-year high before pulling back with the market. Look for support from the long-term trend on any weakness."

    QCOR is a debt free company with $130 million on hand. They are making a ton of money, and earnings just continue to grow. At some point soon these qualities will be important again, and the share price will double or triple.